2024. 5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Medicine and Pharmacy Reports. 97, 4 (Sep. 2024), 488–506. DOI:https://doi.org/10.15386/mpr-2777.